Search
🏅

Vaxdigm Co., Ltd.

No.
4
Sectors
1. 年轻人喜爱的创新性食品饮料相关技术
3. 中老年市场乳制品相关创新技术
Business
Vaxdigm have been developing the technology of CHAPERNA and registered the patents to develop anti-aging food and pharmaceuticals. The patents can be utilized to develop lots of protein-based products including anti-aging food and pharmaceuticals with minimum cost. We want the collaboration with bio companies in Korea as well as outside of Korea.
Funding Rounds
Pre-A
Head Count
11~50
Deck
01_Vaxdigm, IR deck, 1, Sep, 2024-Yili group.pdf
Meetup
1 more property
Vaxdigm is a bio venture to develop anti-aging foods and pharmaceuticals. We have the technology and patents to produce the folded & functional protein products within E Coli. The name of technology and patents is CHAPERNA (Chaperone + RNA) which means the technology (the platform) has the function of chaperone (protein folding) in RNA level. We had developed the technology by the collaboration with Yonsei University, Seoul, Korea.
Homepage

IR Deck / Confidiential

This IR Deck is available for viewing only, not downloading. We may provide an updated version of the deck for pre-sharing on the day of the event.
Loading PDF…

Product/Service

Vaxdigm have been developing the technology of CHAPERNA and registered the patents to develop anti-aging food and pharmaceuticals. The patents can be utilized to develop lots of protein-based products including anti-aging food and pharmaceuticals with minimum cost. We want the collaboration with bio companies in Korea as well as outside of Korea.